Cargando…
Towards personalized tumor markers
The cancer biomarker discovery pipeline is progressing slowly. The difficulties of finding novel and effective biomarkers for diagnosis and management of cancer patients are well-known. We speculate that it is unlikely to discover new serological biomarkers characterized by high sensitivity and spec...
Autores principales: | Kulasingam, Vathany, Prassas, Ioannis, Diamandis, Eleftherios P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871887/ https://www.ncbi.nlm.nih.gov/pubmed/29872704 http://dx.doi.org/10.1038/s41698-017-0021-2 |
Ejemplares similares
-
Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden
por: Ren, Annie, et al.
Publicado: (2021) -
Investigating a novel multiplex proteomics technology for detection of changes in serum protein concentrations that may correlate to tumor burden
por: Ren, Annie He, et al.
Publicado: (2020) -
Fascin-1 is a novel biomarker of aggressiveness in some carcinomas
por: Kulasingam, Vathany, et al.
Publicado: (2013) -
Genomic profiling for copy number changes in plasma of ovarian cancer patients – a new era for cancer diagnostics?
por: Kulasingam, Vathany, et al.
Publicado: (2016) -
Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification
por: Ren, Annie H., et al.
Publicado: (2021)